Your browser doesn't support javascript.
loading
Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.
Dorff, Tanya; Kashid, Sheetal R; Murthy, Vedang; Lombardo, Riccardo; De Nunzio, Cosimo.
Afiliação
  • Dorff T; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Kashid SR; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Murthy V; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Lombardo R; Sapienza University, Rome, Italy.
  • De Nunzio C; Sapienza University, Rome, Italy. cosimodenunzio@virgilio.it.
Article em En | MEDLINE | ID: mdl-38643307
ABSTRACT
The systematic review by Saouli et al. investigates the role of radical prostatectomy (RP) in managing oligometastatic prostate cancer (omPCa) [1]. They analyzed the existing literature to assess the oncological and functional outcomes of RP for these patients. RP is feasible and has an acceptable risk of complications. However, the lack of consensus on the definitions of omPCa and the low-quality evidence of the available comparative and retrospective studies, RP in omPCa should not be recommended outside of clinical trials.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article